Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Thunen Shelley B. Insider active across 2 companies, notably RxSight, Inc.. Cumulatively, 13 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €411k. Activity tracked since 15 December 2023. The latest transaction was disclosed on 14 April 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Thunen Shelley B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
222,684 sharesClass A Common StockSEC:0001104659-26-076515:0
7,792 shares@ US$4.33861.8% of flowCommon StockSEC:0000950170-25-054439:0
15,000 shares@ US$16.0013.3% of flowCommon StockSEC:0000950170-24-111461:0
36,021 shares0Class A Common StockSEC:0001104659-24-097060:0
16,505 shares@ US$4.344.0% of flowCommon StockSEC:0000950170-24-084038:0
10,000 shares@ US$15.59838.9% of flowCommon StockSEC:0000950170-24-080522:0
10,247 shares@ US$15.59839.1% of flowCommon StockSEC:0000950170-24-052283:0
8,857 shares@ US$49.814525.2% of flowCommon StockSEC:0000950170-24-040174:0
10,000 shares@ US$15.59838.8% of flowCommon StockSEC:0000950170-24-025874:0
6,900 shares@ US$4.341.7% of flowCommon StockSEC:0000950170-24-012317:0
4,500 shares@ US$4.341.1% of flowCommon StockSEC:0000950170-24-008423:0
10,000 shares@ US$15.59838.7% of flowCommon StockSEC:0000950170-24-000892:0
20,000 shares@ US$15.6017.4% of flowCommon StockSEC:0001209191-23-059041:0
About Thunen Shelley B
Thunen Shelley B is a declarant linked to AEON Biopharma, Inc. as Director, and to RxSight, Inc. with the role See remarks. They have 13 filings in total, and in the sampled recent filings from 2023-12-18 to 2026-06-22, total sell volume is EUR 410914 and the most common transaction nature is Exercise of options.